OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Release Date
2020
(16)
2025
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
The landscape of viral associations in human cancers.
Not available
S-EPMC8076016
|
biostudies-literature
Cite
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535840
|
biostudies-literature
Cite
Genomic footprints of activated telomere maintenance mechanisms in cancer.
Not available
S-EPMC7002710
|
biostudies-literature
Cite
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Not available
S-EPMC7002586
|
biostudies-literature
Cite
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.
Not available
S-EPMC7002524
|
biostudies-literature
Cite
Divergent mutational processes distinguish hypoxic and normoxic tumours.
Not available
S-EPMC7002770
|
biostudies-literature
Cite
Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Not available
S-EPMC7058535
|
biostudies-literature
Cite
Pan-cancer analysis of whole genomes.
Not available
S-EPMC7025898
|
biostudies-literature
Cite
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer.
Not available
S-EPMC7058537
|
biostudies-literature
Cite
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Not available
S-EPMC7058534
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets